The Enhanced Kentucky All Schedule Prescription Electronic Reporting (eKASPER) program is the Kentucky Prescription Drug Monitoring Program (PDMP) solution for monitoring Schedule II-V controlled substances dispensed in Kentucky. Kentucky Revised Statutes chapter 218A.202 and Kentucky Administrative Regulations 902 KAR 55:110 set forth the legal requirements for reporting Schedule II-V controlled substances dispensed in Kentucky as follows:
KRS 218A.202(1) directs the Cabinet for Health and Family Services to establish an electronic system for monitoring Schedule II, III, IV, and V controlled substances that are dispensed in the Commonwealth by a practitioner or pharmacist or dispensed to an address within the Commonwealth by a pharmacy that has obtained authorization to operate from the Kentucky Board of Pharmacy. KRS 218A.250 requires the cabinet to promulgate administrative regulations pursuant to KRS Chapter 13A for carrying out the provisions of KRS Chapter 218A. The purpose of this administrative regulation is to establish criteria for reporting prescription data, providing reports to authorized persons, and a waiver for a dispenser who does not have an automated recordkeeping system.
The Kentucky Cabinet for Health and Family Services (CHFS) has selected Health Information Designs, LLC (HID) to develop a database that will collect and store prescribing and dispensing data for controlled substances in Schedules II, III, IV, and V and drugs of concern (tramadol). HID’s RxSentry is a web-based program that facilitates the collection, analysis, and reporting of information on the prescribing, dispensing, and use of controlled substance prescription drugs.
RxSentry complies with the Health Insurance Portability and Accountability Act (HIPAA) as it pertains to protected health information (PHI), electronic protected health information (EPHI), and all other relevant state and federal privacy and security laws and regulations. The information collected in the system will be used by CHFS to encourage safer prescribing of controlled substances and reduce drug abuse and diversion within the State of Kentucky.